Cited by 51Liver Disease and TransplantationLiver Diseases and ImmunityDermatology and Skin Diseases

‘Out‐patient’ albumin dialysis for cholestatic patients with intractable pruritus

Open access
Leckie, P., Tritto, G., Mookerjee, R., Davies, N., Jones, D., Jalan, R.·2012·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Intractable pruritus is a major problem for some patients with cholestasis. Albumin dialysis has been shown to ameliorate pruritus, but long‐term outcome data are limited. Aim: To evaluate the safety and efficacy of ‘out‐patient’ albumin dialysis using the molecular adsorbent recirculating system (MARS) in the treatment of intractable pruritus in cholestatic patients referred for liver transplantation for symptomatic relief. Methods: Fifteen patients who failed to respond to standard medical therapy to control pruritus were included. Three MARS (6 h) sessions were performed per admission, and were repeated, if necessary. The intensity and severity of itch was quantified using itch severity and visual analogue scales (ISS and VAS). Results: Molecular adsorbent recirculating system treatment was safe and associated with immediate and complete response in 11 patients; two patients had a partial response and two patients had no response. Thirty‐four treatments were performed during a follow‐up period of 15.7 months (3–46) with patients requiring a mean of two admissions (1–6). The mean VAS and ISS improved significantly (both P < 0.001) with improvement in the patient's perception of their quality of life. The duration of acceptable relief in responders was 3.3 months (range 2–5). No serious adverse events were recorded, but the platelet count and haemoglobin were reduced significantly. Conclusion: Molecular adsorbent recirculating system therapy delivered in an ‘out‐patient’ setting is safe and effective with a high degree of patient acceptability. Albumin dialysis can be considered a viable therapeutic option for patients with severe intractable pruritus, in whom, the only other effective treatment option is liver transplantation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2012.04994.x

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Physical approaches such as nasobiliary drainage, MARS, and UV light therapy are experimental, with case reports or series showing benefit but no formal trial evaluation.

    “Physical approaches, such as nasobiliary drainage [206,189,207,208], molecular absorbance recirculating system (MARS) [209] and ultraviolet (UV) light therapy [210] are all experimental, with case reports/series showing benefit but no formal trial evaluation [210,211].”

    From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [211]

    The Abstract (page unavailable) reports a 15-patient study in which MARS improved pruritus, supporting the claim that a small patient series showed benefit. The paper does not establish the claimed evidence status of nasobiliary drainage or UV light therapy, or show that none of these approaches has undergone formal trial evaluation. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Leckie, P., Tritto, G., Mookerjee, R., Davies, N., Jones, D., & Jalan, R.
Affiliations
  • The Royal Free Hospital (GB)
  • Newcastle University (GB)
Corresponding author
Jalan, R.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2012-01-20
Volume
35
Issue
6
Pages
696-704
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2120452779
Cited by
51
References
34
Citations by year
2026: 2 · 2024: 3 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 8 · 2016: 5 · 2015: 6 · 2014: 2 · 2013: 1 · 2012: 9
FWCI
3.65
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Keywords
intractable pruritus, cholestasis, albumin dialysis, molecular adsorbent recirculating system, outpatient dialysis, liver transplantation, pruritus severity, quality of life, platelet count reduction, hemoglobin decrease
MeSH terms
Adult, Aged, Albumins, Bile Acids and Salts, Cholestasis, Female, Follow-Up Studies, Renal Dialysis, Humans, Male, Middle Aged, Outpatients, Pain Measurement, Platelet Count, Pruritus, Quality of Life, Severity of Illness Index, Time Factors, Dialysis Solutions, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review